126 related articles for article (PubMed ID: 2964669)
21. A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of the xanthine oxidase pathway.
Athar M; Elmets CA; Bickers DR; Mukhtar H
J Clin Invest; 1989 Apr; 83(4):1137-43. PubMed ID: 2539390
[TBL] [Abstract][Full Text] [Related]
22. Tissue retention and adverse reaction after intravenous injection of hematoporphyrin derivatives in dogs.
Okamoto Y; Yonemura D; Miyatake K; Hashimoto Y; Hirano T; Sakata I; Minami S
J Vet Med Sci; 2004 Dec; 66(12):1599-601. PubMed ID: 15644616
[TBL] [Abstract][Full Text] [Related]
23. [Unesthetic consequences of photosensitization induced by injections of hematoporphyrine].
Jean-Pastor MJ; Gamby T; Benveniste MJ; Privat Y
Nouv Presse Med; 1980 Nov; 9(41):3096. PubMed ID: 7443457
[No Abstract] [Full Text] [Related]
24. Phototherapy of bladder cancer: dose/effect relationships.
Haas GP; Shumaker BP; Hetzel FW; Bobrowski R; Lutz MD; Tilley B; Cerny JC
J Urol; 1986 Aug; 136(2):525-8. PubMed ID: 2942706
[TBL] [Abstract][Full Text] [Related]
25. Complications of whole bladder dihematoporphyrin ether photodynamic therapy.
Harty JI; Amin M; Wieman TJ; Tseng MT; Ackerman D; Broghamer W
J Urol; 1989 Jun; 141(6):1341-6. PubMed ID: 2524602
[TBL] [Abstract][Full Text] [Related]
26. A practical test for in vitro evaluation of photosensitization: assessment with hematoporphyrin derivative (HPD).
Croisy A; Carrez D; Zilberfarb D
Cytotechnology; 1990 Mar; 3(2):171-8. PubMed ID: 1368556
[TBL] [Abstract][Full Text] [Related]
27. Potential applications of photoradiation therapy in head and neck surgery.
Ossoff RH; Pelzer HJ; Atiyah RA; Berktold RE; Sisson GA
Arch Otolaryngol; 1984 Nov; 110(11):728-30. PubMed ID: 6207803
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic effects on the nuclear envelope of human skin fibroblasts.
Krammer B; Hubmer A; Hermann A
J Photochem Photobiol B; 1993 Feb; 17(2):109-14. PubMed ID: 8459315
[TBL] [Abstract][Full Text] [Related]
29. meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity.
Berenbaum MC; Akande SL; Bonnett R; Kaur H; Ioannou S; White RD; Winfield UJ
Br J Cancer; 1986 Nov; 54(5):717-25. PubMed ID: 2948536
[TBL] [Abstract][Full Text] [Related]
30. Binding of hematoporphyrin derivative to brain tumor cells--a fluorescence spectroscopic study.
Joshi K; Joshi PG; Joshi NB
Photochem Photobiol; 1992 Jan; 55(1):113-8. PubMed ID: 1534907
[TBL] [Abstract][Full Text] [Related]
31. Phototoxicity of the chemotherapeutic agents hematoporphyrin D, meso-tetra(p-sulfophenyl)porphine and zinc-tetra(p-sulfophenyl)porphine.
Grenan M; Tsutsui M; Wysor M
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):317-27. PubMed ID: 6449725
[TBL] [Abstract][Full Text] [Related]
32. The effect of hematoporphyrin derivative and human erythrocyte ghost encapsulated hematoporphyrin derivative on a mouse myeloma cell line.
McHale AP; McHale ML; Blau W
Cancer Biochem Biophys; 1988 Nov; 10(2):157-64. PubMed ID: 2978120
[TBL] [Abstract][Full Text] [Related]
33. Comparison of photosensitizers in saline and liposomes for tumor photodynamic therapy and skin phototoxicity.
Davis RK; Straight R; Kereszti Z
Laryngoscope; 1990 Jul; 100(7):682-6. PubMed ID: 2362527
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous porphyrin photosensitization: murine ear swelling as a marker of the acute response.
Hawkins CW; Bickers DR; Mukhtar H; Elmets CA
J Invest Dermatol; 1986 Jun; 86(6):638-42. PubMed ID: 3711677
[TBL] [Abstract][Full Text] [Related]
35. The photodynamic effects of photofrin II, hematoporphyrin derivative, hematoporphyrin, and tetrasodium-mesotetra(4-sulfonatophenyl)porphine in vitro: clonogenic cell survival and drug uptake studies.
West CM; Moore JV
Photochem Photobiol; 1989 Feb; 49(2):169-74. PubMed ID: 2523543
[TBL] [Abstract][Full Text] [Related]
36. Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and aluminium sulphonated phthalocyanine (AlSPc): a comparative study.
Tralau CJ; Young AR; Walker NP; Vernon DI; MacRobert AJ; Brown SB; Bown SG
Photochem Photobiol; 1989 Mar; 49(3):305-12. PubMed ID: 2525261
[TBL] [Abstract][Full Text] [Related]
37. The partition and distribution of porphyrins in liposomal membranes. A spectroscopic study.
Gross E; Ehrenberg B
Biochim Biophys Acta; 1989 Jul; 983(1):118-22. PubMed ID: 2527063
[TBL] [Abstract][Full Text] [Related]
38. Chemistry and biological activity of hematoporphyrin derivative (HPD) and photofrin II on human cancerous cells.
De Rosa A; De Simone F; Ramundo E; Rizzo A; Marziani R
J Chemother; 1989 Jul; 1(4 Suppl):1148-50. PubMed ID: 16312811
[No Abstract] [Full Text] [Related]
39. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
Wang Y; Lin Y; Zhang HG; Zhu J
J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence diagnosis of cancer.
Profio AE; Balchum OJ
Adv Exp Med Biol; 1985; 193():43-50. PubMed ID: 2937270
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
